国家限制类技术临床应用管理规范(2022年版)

2022-04-20 中华人民共和国国家卫生健康委员会 卫健委官网

为进一步加强医疗技术临床应用事中事后监管,做好限制类技术临床应用管理,保障医疗质量和医疗安全,根据《医疗技术临床应用管理办法》,结合限制类技术临床应用实际情况,卫健委组织对2017年版国家限制类技术目

中文标题:

国家限制类技术临床应用管理规范(2022年版)

发布日期:

2022-04-20

简要介绍:

为进一步加强医疗技术临床应用事中事后监管,做好限制类技术临床应用管理,保障医疗质量和医疗安全,根据《医疗技术临床应用管理办法》,结合限制类技术临床应用实际情况,卫健委组织对2017年版国家限制类技术目录及临床应用管理规范进行修订,形成了《国家限制类技术目录(2022年版)》《国家限制类技术临床应用管理规范(2022年版)》。

《国家限制类技术目录(2022年版)》和《国家限制类技术临床应用管理规范(2022年版)》自本通知印发之日起施行。《国家卫生计生委办公厅关于印发造血干细胞移植技术管理规范(2017年版)等15个“限制临床应用”医疗技术管理规范和质量控制指标的通知》(国卫办医发〔2017〕7号)和《国家卫生健康委办公厅关于印发体外膜肺氧合(ECMO)技术临床应用管理规范的通知》(国卫办医函〔2020〕763号)同时废止。

相关资料下载:
[AttachmentFileName(sort=1, fileName=国家限制类技术临床应用管理规范(2022年版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=c67fd1c002a18849, title=国家限制类技术临床应用管理规范(2022年版), enTitle=, guiderFrom=卫健委官网, authorId=0, author=, summary=为进一步加强医疗技术临床应用事中事后监管,做好限制类技术临床应用管理,保障医疗质量和医疗安全,根据《医疗技术临床应用管理办法》,结合限制类技术临床应用实际情况,卫健委组织对2017年版国家限制类技术目, cover=https://img.medsci.cn/20220422/1650642692982_5579292.jpg, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Apr 20 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #484848;">为进一步加强医疗技术临床应用事中事后监管,做好限制类技术临床应用管理,保障医疗质量和医疗安全,根据《医疗技术临床应用管理办法》,结合限制类技术临床应用实际情况,卫健委组织对2017年版国家限制类技术目录及临床应用管理规范进行修订,形成了《国家限制类技术目录(2022年版)》</span><span style="color: #484848;">和</span><span style="color: #484848;">《国家限制类技术临床应用管理规范(2022年版)》。</span></p> <p><span style="color: #484848;">《国家限制类技术目录(2022年版)》和《国家限制类技术临床应用管理规范(2022年版)》自本通知印发之日起施行。《国家卫生计生委办公厅关于印发造血干细胞移植技术管理规范(2017年版)等15个&ldquo;限制临床应用&rdquo;医疗技术管理规范和质量控制指标的通知》(国卫办医发〔2017〕7号)和《国家卫生健康委办公厅关于印发体外膜肺氧合(ECMO)技术临床应用管理规范的通知》(国卫办医函〔2020〕763号)同时废止。</span></p>, tagList=[TagDto(tagId=437059, tagName=国家限制类技术)], categoryList=[CategoryDto(categoryId=35, categoryName=预防公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4287, appHits=111, showAppHits=0, pcHits=386, showPcHits=4176, likes=2, shares=28, comments=5, approvalStatus=1, publishedTime=Sat Apr 23 15:50:00 CST 2022, publishedTimeString=2022-04-20, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Apr 22 23:53:18 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 20:24:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=国家限制类技术临床应用管理规范(2022年版).pdf)])
国家限制类技术临床应用管理规范(2022年版).pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214794, encodeId=26361214e941d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:11:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214060, encodeId=fbc4121406080, content=版本别的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d5c5414254, createdName=ms8000000775044569, createdTime=Mon Apr 25 10:42:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213808, encodeId=d4f912138087b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Sun Apr 24 07:16:14 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213702, encodeId=00a41213e02fc, content=👏🏻👏🏻👏🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42958131897, createdName=ms5000000550740804, createdTime=Sat Apr 23 16:32:00 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214794, encodeId=26361214e941d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:11:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214060, encodeId=fbc4121406080, content=版本别的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d5c5414254, createdName=ms8000000775044569, createdTime=Mon Apr 25 10:42:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213808, encodeId=d4f912138087b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Sun Apr 24 07:16:14 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213702, encodeId=00a41213e02fc, content=👏🏻👏🏻👏🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42958131897, createdName=ms5000000550740804, createdTime=Sat Apr 23 16:32:00 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
    2022-04-25 ms8000000775044569

    版本别的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214794, encodeId=26361214e941d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:11:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214060, encodeId=fbc4121406080, content=版本别的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d5c5414254, createdName=ms8000000775044569, createdTime=Mon Apr 25 10:42:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213808, encodeId=d4f912138087b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Sun Apr 24 07:16:14 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213702, encodeId=00a41213e02fc, content=👏🏻👏🏻👏🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42958131897, createdName=ms5000000550740804, createdTime=Sat Apr 23 16:32:00 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1214794, encodeId=26361214e941d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:11:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214060, encodeId=fbc4121406080, content=版本别的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d5c5414254, createdName=ms8000000775044569, createdTime=Mon Apr 25 10:42:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213808, encodeId=d4f912138087b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Sun Apr 24 07:16:14 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213702, encodeId=00a41213e02fc, content=👏🏻👏🏻👏🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42958131897, createdName=ms5000000550740804, createdTime=Sat Apr 23 16:32:00 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
    2022-04-23 ms5000000550740804

    👏🏻👏🏻👏🏻

    0